Modern Healthcare Technology Holdings (HKG:919) Full Year 2025 Results
Key Financial Results
- Revenue: HK$456.0m (flat on FY 2024).
- Net loss: HK$5.07m (loss narrowed by 47% from FY 2024).
- HK$0.006 loss per share (improved from HK$0.011 loss in FY 2024).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Modern Healthcare Technology Holdings shares are up 8.9% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 2 warning signs for Modern Healthcare Technology Holdings you should be aware of, and 1 of them shouldn't be ignored.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks
Try a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.